<!DOCTYPE article
 PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.2 20190208//EN" "JATS-archivearticle1.dtd">
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="preprint"><?all-math-mml yes?><?use-mml?><?origin ukpmcpa?><front><journal-meta><journal-id journal-id-type="nlm-ta">bioRxiv</journal-id><journal-title-group><journal-title>bioRxiv : the preprint server for biology</journal-title></journal-title-group><issn pub-type="ppub"/></journal-meta><article-meta><article-id pub-id-type="manuscript">EMS191470</article-id><article-id pub-id-type="doi">10.1101/2023.11.20.567968</article-id><article-id pub-id-type="archive">PPR762415</article-id><article-version-alternatives><article-version article-version-type="status">preprint</article-version><article-version article-version-type="number">1</article-version></article-version-alternatives><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>BRCA2 stabilises RAD51 and DMC1 nucleoprotein filaments through a conserved interaction mode</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Dunce</surname><given-names>James M.</given-names></name><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Davies</surname><given-names>Owen R.</given-names></name><xref ref-type="aff" rid="A2">2</xref></contrib></contrib-group><aff id="A1"><label>1</label>Department of Biochemistry, University of Cambridge, 80 Tennis Court Road, Old Addenbrookes Site, Cambridge CB2 1GA, UK</aff><aff id="A2"><label>2</label>Wellcome Centre for Cell Biology, Institute of Cell Biology, University of Edinburgh, Michael Swann Building, Max Born Crescent, Edinburgh EH9 3BF, United Kingdom</aff><author-notes><corresp id="CR1"><bold>Author for Correspondence</bold> Owen Davies: <email>owen.davies@ed.ac.uk</email></corresp></author-notes><pub-date pub-type="nihms-submitted"><day>22</day><month>11</month><year>2023</year></pub-date><pub-date pub-type="preprint"><day>21</day><month>11</month><year>2023</year></pub-date><permissions><ali:free_to_read/><license><ali:license_ref>https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This work is licensed under a <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">CC BY 4.0 International license</ext-link>.</license-p></license></permissions><abstract><p id="P1">BRCA2 is essential for DNA repair by homologous recombination in mitosis and meiosis. It interacts with recombinases RAD51 and DMC1 to facilitate the formation of nucleoprotein filaments on resected DNA ends that catalyse recombination-mediated repair. BRCA2’s BRC repeats bind and disrupt RAD51 and DMC1 filaments, whereas its PhePP motifs binds to recombinases in a manner that stabilises their nucleoprotein filaments. However, the mechanism of filament stabilisation has hitherto remained unknown. Here, we report the crystal structure of a BRCA2-DMC1 complex, revealing how PhePP motifs bind to recombinases. This novel mode of interaction is conserved for RAD51 and DMC1, which selectively bind to BRCA2’s two distinct PhePP motifs. In both cases, BRCA2 PhePP motifs enhance the stability of nucleoprotein filaments, protecting them from BRC-mediated disruption. Hence, we report the structural basis of how BRCA2’s PhePP motifs stabilise RAD51 and DMC1 nucleoprotein filaments for their essential roles in mitotic and meiotic recombination.</p></abstract><kwd-group><kwd>DNA repair</kwd><kwd>recombination</kwd><kwd>BRCA2</kwd><kwd>RAD51</kwd><kwd>DMC1</kwd><kwd>meiosis</kwd><kwd>X-ray crystallography</kwd><kwd>molecular modelling</kwd></kwd-group></article-meta></front><body><sec id="S1" sec-type="intro"><title>Introduction</title><p id="P2">DNA double-strand break (DSB) repair by homologous recombination is critical for genome integrity and fertility (<xref ref-type="bibr" rid="R33">Page and Hawley, 2003</xref>, <xref ref-type="bibr" rid="R52">Wright et al., 2018</xref>, <xref ref-type="bibr" rid="R42">Sun et al., 2020</xref>). In somatic cells, DSBs arise due to exogenous damage and upon replication fork collapse (<xref ref-type="bibr" rid="R52">Wright et al., 2018</xref>). These lesions can be repaired, and replication restarted, through inter-sister recombination, of which the machinery has an additional role in protecting stalled replication forks (<xref ref-type="bibr" rid="R20">Feng and Jasin, 2017</xref>, <xref ref-type="bibr" rid="R48">Tye et al., 2021</xref>). In meiosis, a programme of DSB induction triggers inter-homologue recombination (<xref ref-type="bibr" rid="R33">Page and Hawley, 2003</xref>), enabling synapsis between homologues (<xref ref-type="bibr" rid="R1">Adams and Davies, 2023</xref>), and the formation of crossovers that ensure correct chromosome segregation and enhance genetic diversity (<xref ref-type="bibr" rid="R23">Hunter, 2015</xref>, <xref ref-type="bibr" rid="R60">Zickler and Kleckner, 2015</xref>). Hence, defects in homologous recombination are associated with chromosome instability, increased cancer risk and infertility (<xref ref-type="bibr" rid="R22">Hall et al., 1990</xref>, <xref ref-type="bibr" rid="R34">Patel et al., 1998</xref>, <xref ref-type="bibr" rid="R40">Sharan et al., 2004</xref>).</p><p id="P3">The tumour suppressor BRCA2 performs a central role in the mechanics of recombination by loading recombinases onto resected DNA ends to form nucleoprotein filaments that mediate strand invasion and homology search within the template DNA (<xref ref-type="bibr" rid="R25">Jensen et al., 2010</xref>, <xref ref-type="bibr" rid="R30">Liu et al., 2010</xref>, <xref ref-type="bibr" rid="R44">Thorslund et al., 2010</xref>). This involves the displacement of RPA from newly resected DNA ends (<xref ref-type="bibr" rid="R38">Shahid et al., 2014</xref>, <xref ref-type="bibr" rid="R5">Bell et al., 2023</xref>), and the remodelling of recombinases from their oligomeric assemblies into protein-DNA filaments that are active in recombination (<xref ref-type="bibr" rid="R25">Jensen et al., 2010</xref>, <xref ref-type="bibr" rid="R30">Liu et al., 2010</xref>, <xref ref-type="bibr" rid="R44">Thorslund et al., 2010</xref>). Whilst RAD51 is the universal recombinase, meiosis also requires DMC1 (<xref ref-type="bibr" rid="R54">Yoshida et al., 1998</xref>, <xref ref-type="bibr" rid="R37">Pittman et al., 1998</xref>), which enables mismatch-tolerant inter-homologue recombination (<xref ref-type="bibr" rid="R29">Lee et al., 2015</xref>). BRCA2 and RAD51 knockouts are embryonically lethal (<xref ref-type="bibr" rid="R47">Tsuzuki et al., 1996</xref>, <xref ref-type="bibr" rid="R39">Sharan et al., 1997</xref>), their disruption in cell lines leads to gross chromosomal rearrangements (<xref ref-type="bibr" rid="R41">Sonoda et al., 1998</xref>, <xref ref-type="bibr" rid="R34">Patel et al., 1998</xref>, <xref ref-type="bibr" rid="R55">Yu et al., 2000</xref>), and human BRCA2 mutations are strongly associated with early-onset breast and ovarian cancers (<xref ref-type="bibr" rid="R22">Hall et al., 1990</xref>). Further, DMC1 disruption, and germline-specific deficiencies of BRCA2 and RAD51, lead to meiotic impairment and infertility (<xref ref-type="bibr" rid="R54">Yoshida et al., 1998</xref>, <xref ref-type="bibr" rid="R37">Pittman et al., 1998</xref>, <xref ref-type="bibr" rid="R40">Sharan et al., 2004</xref>, <xref ref-type="bibr" rid="R10">Dai et al., 2017</xref>).</p><p id="P4">BRCA2 interacts with RAD51 and DMC1 recombinases through BRC repeats and PhePP motifs (<xref ref-type="fig" rid="F1">Figure 1a</xref>) (<xref ref-type="bibr" rid="R39">Sharan et al., 1997</xref>, <xref ref-type="bibr" rid="R51">Wong et al., 1997</xref>, <xref ref-type="bibr" rid="R11">Davies et al., 2001</xref>, <xref ref-type="bibr" rid="R17">Esashi et al., 2005</xref>, <xref ref-type="bibr" rid="R45">Thorslund and West, 2007</xref>). The eight BRC repeats, located within BRCA2’s central exon 11 region, bind to RAD51 and DMC1 with various affinities (<xref ref-type="bibr" rid="R51">Wong et al., 1997</xref>, <xref ref-type="bibr" rid="R7">Carreira and Kowalczykowski, 2011</xref>, <xref ref-type="bibr" rid="R31">Martinez et al., 2016</xref>). They interact via molecular mimicry with the self-association interface that mediates the oligomeric assembly and nucleoprotein filament formation of recombinases, by locking them in inactive monomeric states (<xref ref-type="bibr" rid="R35">Pellegrini et al., 2002</xref>). Hence, BRC repeats are thought to remodel RAD51 and DMC1, from their isolated states in large filamentous structures and octameric rings, respectively, to nucleate their assembly on resected DNA ends into active nucleoprotein filaments. BRCA2 has two PhePP motifs, located within exons 14 and 27 (herein referred to as Ex14 and Ex27, respectively; <xref ref-type="fig" rid="F1">Figure 1a</xref>) (<xref ref-type="bibr" rid="R39">Sharan et al., 1997</xref>, <xref ref-type="bibr" rid="R17">Esashi et al., 2005</xref>, <xref ref-type="bibr" rid="R43">Thorslund et al., 2007</xref>). Whilst Ex14 and Ex27 share an eponymous FxPP motif, their sequences are otherwise divergent (<xref ref-type="fig" rid="F1">Figure 1a</xref>), and they demonstrate specificity for DMC1- and RAD51-binding, respectively (<xref ref-type="bibr" rid="R39">Sharan et al., 1997</xref>, <xref ref-type="bibr" rid="R17">Esashi et al., 2005</xref>, <xref ref-type="bibr" rid="R43">Thorslund et al., 2007</xref>). Importantly, Ex27 binds to RAD51 filaments, rather than monomers, and protects nucleoprotein filaments from BRC-mediated disruption (<xref ref-type="bibr" rid="R12">Davies and Pellegrini, 2007</xref>, <xref ref-type="bibr" rid="R18">Esashi et al., 2007</xref>). However, it remains unknown how PhePP motifs interact with recombinases.</p><p id="P5">Here, we report the crystal structure of BRCA2 Ex14 bound to DMC1, and that BRCA2 Ex27 binds to RAD51 through the same core interaction mode. Hence, we uncover the structural basis of how BRCA2 PhePP motifs bind to RAD51 and DMC1 recombinases and stabilise their nucleoprotein filaments for mitotic and meiotic recombination.</p></sec><sec id="S2" sec-type="results"><title>Results</title><sec id="S3"><title>Crystal structure of a BRCA2-DMC1 complex</title><p id="P6">The mode of interaction between BRCA2’s PhePP motifs and recombinases has remained unknown since the discovery of this filament-stabilising binding site over two decades ago (<xref ref-type="bibr" rid="R39">Sharan et al., 1997</xref>, <xref ref-type="bibr" rid="R17">Esashi et al., 2005</xref>, <xref ref-type="bibr" rid="R12">Davies and Pellegrini, 2007</xref>, <xref ref-type="bibr" rid="R18">Esashi et al., 2007</xref>). As DMC1 exists in octameric rings, whereas RAD51 forms filaments, we reasoned that DMC1 may be more amenable for structure solution of a BRCA2 PhePP-bound complex. Hence, we established a crystallisation system for the structural core of human DMC1 in which its N-terminal domain was deleted (herein referred to as DMC1 ΔN; amino-acids 83-340). We first validated this system by determining the native structure to a resolution of 2.05 Å, using a previous DMC1 structure (PDB accession 4HYY: <xref ref-type="bibr" rid="R14">Du and Luo, 2013</xref>) as a template for molecular replacement (<xref ref-type="table" rid="T1">Table 1</xref>). We then soaked DMC1 ΔN crystals with a peptide corresponding to a truncated form of BRCA2’s Ex14 (herein referred to as Ex14-Tr; amino-acids 24012414). Whilst soaking substantially reduced crystal quality, we obtained X-ray diffraction data to anisotropic resolution limits of 3.40–5.80 Å, in which additional peptide density was clearly observed (<xref ref-type="fig" rid="F1">Figure 1b</xref>, <xref ref-type="table" rid="T1">Table 1</xref> and <xref ref-type="supplementary-material" rid="SD1">Supplementary Figure 1</xref>). The peptide density was located adjacent to a loop formed by DMC1 amino-acids 178-183, which is a crystal lattice contact. Hence, the reduction in resolution upon BRCA2 Ex14-binding is owing to the introduction of a defect in the crystal lattice.</p><p id="P7">The electron density maps of the bound BRCA2 Ex14 peptide could not be interpreted unambiguously (<xref ref-type="supplementary-material" rid="SD1">Supplementary Figure 1</xref>). Nevertheless, we were able to build the BRCA2 Ex14 structure guided by an <italic>Alphafold2</italic> model of the same BRCA2 Ex14 sequence bound to a DMC1 ΔN dimer (<xref ref-type="supplementary-material" rid="SD1">Supplementary Figure 2a-e</xref>). This resulted in a refined model of the peptide at seven out of the eight DMC1 protomers, with more extensive structural information at instances away from rather than at crystal lattice contacts (<xref ref-type="table" rid="T1">Table 1</xref> and <xref ref-type="fig" rid="F1">Figure 1b</xref>). The observed BRCA2 Ex14 peptide contains the PhePP motif (aminoacids 2406-2409), in which F2406 is buried in a hydrophobic pocket and the two consecutive proline residues enable an unusual backbone conformation (<xref ref-type="fig" rid="F1">Figure 1c</xref>). The PhePP-binding site of DMC1 is formed from by two loops, corresponding to amino-acids 147-153 and 178-183. Importantly, the first loop corresponds to one of the most divergent regions between DMC1 and RAD51 (<xref ref-type="supplementary-material" rid="SD1">Supplementary Figure 3</xref>), which may explain the reported differences in Ex14- and Ex27-binding of RAD51 and DMC1 (<xref ref-type="bibr" rid="R39">Sharan et al., 1997</xref>, <xref ref-type="bibr" rid="R17">Esashi et al., 2005</xref>, <xref ref-type="bibr" rid="R43">Thorslund et al., 2007</xref>). The second loop incudes amino-acid residues V179 (DMC1) and L180 (RAD51) that substantially contribute to the hydrophobic pocket of the differential PhePP-binding site (<xref ref-type="fig" rid="F1">Figure 1d</xref>).</p></sec><sec id="S4"><title>BRCA2’s PhePP motifs mediate selective RAD51- and DMC1-binding</title><p id="P8">We next validated the BRCA2-DMC1 structure through interaction studies. Microscale thermophoresis (MST) confirmed that DMC1 ΔN binds to Ex14 (amino-acids 2387-2420) with a <italic>K<sub>D</sub></italic> of approximately 30 μM, which is over threefold higher affinity than Ex27 (<xref ref-type="fig" rid="F1">Figure 1e</xref> and <xref ref-type="supplementary-material" rid="SD1">Supplementary Figure 4</xref>). Further, the binding affinity was largely retained for the truncated Ex14-Tr peptide used in crystallographic studies (<xref ref-type="fig" rid="F1">Figure 1e</xref> and <xref ref-type="supplementary-material" rid="SD1">Supplementary Figure 4</xref>). In contrast, the interaction was largely disrupted upon introduction of alanine mutations of the PhePP motif (herein referred to as Ex14-AAA; amino-acids F2406A, P2408A, P2409A) (<xref ref-type="fig" rid="F1">Figure 1e</xref>). These MST results agree with biochemical pull-down assays, in which DMC1 ΔN was shown to bind to Ex14, Ex14-Tr and BRC4, but not Ex14-AAA or Ex27 (<xref ref-type="fig" rid="F1">Figure 1f</xref>).</p><p id="P9">To confirm the interaction site on the DMC1 recombinase, we used a mutant in which the loops that form the PhePP-binding site of DMC1 were replaced by the sequences present in RAD51 (herein referred to as DMC1 loop mutant, in which loops 147-GAGGYPG-153 and 178-NVDHDA-183 were mutated to IDRGGGE and GLSGSD, respectively). The DMC1 loop mutant abolished Ex14-binding, confirming that we had identified the correct PhePP-binding site (<xref ref-type="fig" rid="F1">Figures 1e,g</xref>). However, it also failed to interact with Ex27, indicating that additional contacts must contribute to Ex27-binding by RAD51 (<xref ref-type="fig" rid="F1">Figure 1g</xref>). Finally, we used a monomeric DMC1 F85E mutant to demonstrate that Ex14 only binds to oligomeric DMC1, whereas BRC4 binds to both monomeric and oligomeric forms (<xref ref-type="fig" rid="F1">Figure 1h</xref>). Hence, similar to the BRCA2 Ex27-RAD51 interaction (<xref ref-type="bibr" rid="R18">Esashi et al., 2007</xref>, <xref ref-type="bibr" rid="R12">Davies and Pellegrini, 2007</xref>), we find that BRCA2 Ex14 selectively binds to oligomeric DMC1 at a site formed by residues including V179.</p></sec><sec id="S5"><title>BRCA2 Ex14 stabilises DMC1 nucleoprotein filaments</title><p id="P10">What is the function of the BRCA2 Ex14-DMC1 interaction? We used electrophoretic mobility shift assays (EMSAs) to assay the impact of BRCA2-binding on DMC1 nucleoprotein filaments. Firstly, using unfavourable nucleoprotein filament assembly conditions (tris, acetate, EDTA; pH 7.5), we showed that BRCA2 Ex14 promotes the formation of DMC1-ssDNA nucleoprotein filaments (<xref ref-type="fig" rid="F2">Figure 2a</xref>). We then used favourable nucleoprotein filament assembly conditions (triethanolamine + KCl; pH 7.5) to show that BRCA2 Ex14 binds to pre-formed DMC1-ssDNA filaments, inducing a substantial super-shift (<xref ref-type="fig" rid="F2">Figure 2b</xref>). Finally, we demonstrated that binding of BRCA2 Ex14 protects DMC1-ssDNA nucleoprotein filaments from BRC4-mediated disruption (<xref ref-type="fig" rid="F2">Figure 2c</xref>). Importantly, promotion of assembly, stabilisation and protection of DMC1-ssDNA nucleoprotein filaments were abolished by the Ex14-AAA PhePP mutation (<xref ref-type="fig" rid="F2">Figure 2a-c</xref>), indicating that these functions depend on the interaction observed in our BRCA2-DMC1 crystal structure. Hence, BRCA2 Ex14 binds to DMC1 via the PhePP motif, promoting the formation of DMC1-ssDNA nucleoprotein filaments, and protecting filaments from BRC4-mediated disruption, in the same way as was previously observed for the BRCA2 Ex27-RAD51 interaction (<xref ref-type="bibr" rid="R18">Esashi et al., 2007</xref>, <xref ref-type="bibr" rid="R12">Davies and Pellegrini, 2007</xref>).</p></sec><sec id="S6"><title>BRCA2 Ex27 binds to RAD51 through a conserved interaction mode</title><p id="P11">We wondered whether BRCA2 PhePP motifs bind to RAD51 and DMC1 recombinases through the same interaction mode. Firstly, we built an <italic>Alphafold2</italic> model of BRCA2 Ex27 bound to a RAD51 dimer (<xref ref-type="supplementary-material" rid="SD1">Supplementary Figure 5a-e</xref>). We then built a model of BRCA2 Ex27 bound to a RAD51 filament by docking our BRCA2-RAD51 model onto a cryo-EM structure of the RAD51 filament (PDB accession 8BSC; <xref ref-type="bibr" rid="R3">Appleby et al., 2023a</xref>). We noticed that the N-terminal end of the modelled BRCA2 Ex27 peptide clashed with RAD51 self-association interactions, so removed this and restricted the extent of the Ex27 peptide to amino-acids 3278-3309 (<xref ref-type="fig" rid="F3">Figure 3a</xref>). The resultant model predicts that BRC2 Ex27 binds via precisely the same core PhePP interface as observed in our BRCA2-DMC1 crystal structure (<xref ref-type="fig" rid="F3">Figure 3b,c</xref>). Further, the model predicts that the N-terminal end of BRCA2 Ex27 binds across RAD51’s self-association interface, explaining how it protects filaments from BRC4-mediated disruption (<xref ref-type="bibr" rid="R18">Esashi et al., 2007</xref>, <xref ref-type="bibr" rid="R12">Davies and Pellegrini, 2007</xref>). Hence, the N-terminal end of BRCA2 Ex14 likely binds across the DMC1 self-association interface in a similar manner to protect from BRC repeat disruption.</p><p id="P12">We next validated our BRCA2-RAD51 model. Pull-down assays confirmed that RAD51 binds selectively to BRCA2 Ex27 rather than Ex14, in a manner that is disrupted by mutation of the PhePP motif (herein referred to as BRCA2 Ex27-AAA; amino-acids F3308A, P3310A, P3311A) (<xref ref-type="fig" rid="F3">Figure 3d</xref>). Further, we found that protection of RAD51-ssDNA nucleoprotein filaments from BRC4-mediated disruption is abrogated by the BRCA2 Ex27-AAA mutant and by an L180E mutation that targets the divergent loop of RAD51’s PhePP-binding site (<xref ref-type="fig" rid="F3">Figure 3e</xref>). Hence, BRCA2 Ex27 confers protection to RAD51-ssDNA nucleoprotein filaments by binding to RAD51’s PhePP-binding site in the same manner as observed in our crystal structure of BRCA2-DMC1. Thus, we conclude that BRCA2’s PhePP motifs bind selectively to RAD51 and DMC1 nucleoprotein filaments through a conserved interaction mode that stabilises filaments from BRC4-mediated disruption.</p></sec></sec><sec id="S7" sec-type="discussion"><title>Discussion</title><p id="P13">The interaction mode between BRCA2’s PhePP motifs and recombinases had remained unknown. Here, we have presented a crystal structure of the BRCA2-DMC1 complex, and solution data, in which we reveal a novel interaction mode, which is conserved between BRCA2’s Ex14 and Ex27 PhePP motifs and recombinases DMC1 and RAD51, respectively. Further, similar PhePP motifs have been reported in other recombinases-interacting proteins, including RAD51AP1 and FIGNL1 (<xref ref-type="bibr" rid="R15">Dunlop et al., 2011</xref>, <xref ref-type="bibr" rid="R56">Yuan and Chen, 2013</xref>), and are observable in the sequences of other proteins such as SYCP1 (<xref ref-type="bibr" rid="R9">Crichton et al., 2023</xref>) and RECQL5 (<xref ref-type="bibr" rid="R24">Islam et al., 2012</xref>). Hence, this may be a general mechanism whereby regulatory factors associate with RAD51 and DMC1 nucleoprotein filaments. Overall, our data support a dichotomy, in which BRCA2’s BRC and PhePP motifs have distinct roles in remodelling recombinases and stabilising nucleoprotein filaments, respectively, in both mitotic and meiotic recombination.</p><p id="P14">How does BRCA2 PhePP-binding confer stability to RAD51 and DMC1 nucleoprotein filaments? The BRCA2-DMC1 crystal structure reported herein shows only the core PhePP interface, which is distant from the recombinase self-association interface. Nevertheless, the BRCA2 Ex27-RAD51 model suggests that the upstream sequence binds across the self-association interface, which would sterically hinder access to the self-association interface, thereby explaining its stabilisation and protection from BRC-mediated disruption (<xref ref-type="bibr" rid="R18">Esashi et al., 2007</xref>, <xref ref-type="bibr" rid="R12">Davies and Pellegrini, 2007</xref>). In a parallel study, a cryo-EM structure of the BRCA2 Ex27-RAD51 complex was reported (<xref ref-type="bibr" rid="R4">Appleby et al., 2023b</xref>), which agrees with the model presented herein. Further, in the cryo-EM structure and in our model, the positively charged N-terminal end of Ex27 is located close to the filament axis, where bound DNA is located. Hence, we suggest that Ex27 further stabilises RAD51 nucleoprotein filaments by its N-terminus binding directly to DNA, in keeping with recent biochemical findings (<xref ref-type="bibr" rid="R28">Kwon et al., 2023</xref>). It is likely that BRCA2 Ex14 confers stability and protection to DMC1 nucleoprotein filaments in a similar manner to Ex27, through its upstream sequence binding across the self-association interface.</p><p id="P15">There are some notable differences in the sequences of BRCA2 Ex14 and Ex27, which must affect their function. Firstly, Ex14 show little conservation outside the PhePP motif (<xref ref-type="bibr" rid="R43">Thorslund et al., 2007</xref>), suggesting that whilst it must extend across the self-association interface to confer protection, it forms fewer recombinase interactions than Ex27. Secondly, Ex14 lacks the CDK phosphorylation site that is present in Ex27 and is responsible for disrupting binding at the G2-M transition (<xref ref-type="bibr" rid="R17">Esashi et al., 2005</xref>). This likely represents the difference between the BRCA2 Ex14-DMC1 interaction functioning in meiosis, and the BRCA2 Ex27-RAD51 interaction functioning in replication fork preservation (<xref ref-type="bibr" rid="R20">Feng and Jasin, 2017</xref>, <xref ref-type="bibr" rid="R48">Tye et al., 2021</xref>, <xref ref-type="bibr" rid="R28">Kwon et al., 2023</xref>).</p><p id="P16">Whilst BRCA2 PhePP interactions have thus far been considered in isolation, they likely operate as part of a wider ‘recombinosome’ structure. BRCA2’s PhePP motifs are located on either side of its C-terminal DNA-binding domain (<xref ref-type="bibr" rid="R53">Yang et al., 2002</xref>). Hence, filament-stabilising interactions by Ex14 and Ex27 may occur cooperatively with DNA-binding and nucleation of nucleoprotein filament formation by BRCA2, which is known to involve displacement of ssDNA-binding protein RPA (<xref ref-type="bibr" rid="R38">Shahid et al., 2014</xref>, <xref ref-type="bibr" rid="R5">Bell et al., 2023</xref>). Further, Ex14 is located adjacent to a binding site of meiotic recombination complex MEILB2-BRME1 (<xref ref-type="bibr" rid="R57">Zhang et al., 2019</xref>, <xref ref-type="bibr" rid="R58">Zhang et al., 2020</xref>), which is proposed to displace meiosis-specific ssDNA-binding complex MEIOB-SPATA22 and act as DNA clamp (<xref ref-type="bibr" rid="R59">Zhang et al., 2022</xref>, <xref ref-type="bibr" rid="R21">Gurusaran et al., 2023</xref>). Hence, BRCA2 may coordinate the formation of a ‘meiotic recombinosome’ in which the key functionalities of meiotic recombination are brought together to enable the loading and stabilisation of DMC1 nucleoprotein filaments for inter-homologue recombination. Our understanding of meiotic recombination would be truly transformed by structure elucidation of this multi-protein assembly.</p></sec><sec id="S8" sec-type="materials | methods"><title>Materials and Methods</title><sec id="S9"><title>Recombinant protein expression and purification</title><p id="P17">The sequences corresponding to human DMC1 (amino acids 1-340) and DMC1 ΔN (83-340) were cloned into pHAT4 (<xref ref-type="bibr" rid="R36">Peranen et al., 1996</xref>) for expression as a TEV-cleavable His6-tag fusion in BL21 (DE3) cells (Novagen®) in 2xYT media, induced with 0.5 mM IPTG for 16 hours at 25°C. Cells were lysed by sonication in 20 mM Tris pH 8.0, 500 mM KCl and fusion proteins were purified from clarified lysate through consecutive Ni-NTA (Qiagen) and HiTrap Q HP (GE Healthcare) ion exchange chromatography. His6-tag removal was mediated by incubation overnight with TEV protease. Cleaved DMC1 was further purified by HiTrapQ HP ion exchange chromatography and size exclusion chromatography (HiLoad™ 16/600 Superdex 200, GE Healthcare) in 20 mM Tris pH 8.0, 150 mM KCl, 2 mM DTT.</p><p id="P18">RAD51 (amino acids 1-339) and RAD51 L180E were co-expressed with an MBP-fusion of BRCA2 BRC4 (amino acids 1519-1551) in BL21 (DE3) cells (Novagen®) in 2xYT media, and induced with 0.5 mM IPTG for 16 hours at 25°C. Cells were lysed by sonication in 20 mM Tris pH 8.0, 500 mM KCl, and the complex of RAD51 and MBP-BRCA2 BRC4 was purified from clarified lysate through consecutive amylose and Ni-NTA (Qiagen) affinity chromatography. The complex was disrupted through HiTrap Q HP (GE Healthcare) ion exchange chromatography, and RAD51 was further purified through HiTrap Heparin HP (GE Healthcare) ion-exchange chromatography and size exclusion chromatography (HiLoad™ 16/600 Superdex 200, GE Healthcare) in 20 mM Tris pH 8.0, 150 mM KCl, 2 mM DTT.</p><p id="P19">The sequences corresponding to human BRCA2 Ex14 (amino acids 2387-2420) and BRCA2 Ex14-AAA were cloned into pMAT11 for expression as TEV-cleavable His6-MBP-tag fusions in BL21 (DE3) cells (Novagen®) in 2xYT media, induced with 0.5 mM IPTG for 16 hours at 25°C. Cells were lysed by sonication in 20 mM Tris pH 8.0, 500 mM KCl and the fusion proteins purified from clarified lysate through consecutive Ni-NTA (Qiagen) and HiTrap Q HP (GE Healthcare) ion exchange chromatography. His6-MBP-tag removal was mediated by incubation overnight with TEV protease. Cleaved BRCA2 Ex14 was further purified by HiTrapSP HP ion exchange chromatography and size exclusion chromatography (HiLoad™ 16/600 Superdex 200, GE Healthcare) in 20 mM Tris pH 8.0, 150 mM KCl, 2 mM DTT.</p><p id="P20">All other BRCA2 peptide sequences utilised in experiments (other than affinity pulldown experiments) were synthesized by Severn Biotech including BRC4 (amino acids 1519-1551), BRCA2 Ex14-Tr (amino acids 2401-2414), BRCA2 Ex27 (3270-3315) and BRCA2 Ex27-AAA.</p><p id="P21">Protein samples were concentrated using 10,000/3,000 MWCO centrifugal units (Amicon) and were stored at -80°C following flash-freezing in liquid nitrogen. Protein samples were analysed by SDS-PAGE with Coomassie staining, and concentrations were determined by UV spectroscopy using a Cary 60 UV spectrophotometer (Agilent) with extinction coefficients and molecular weights calculated by ProtParam (<ext-link ext-link-type="uri" xlink:href="https://web.expasy.org/protparam/">http://web.expasy.org/protparam/</ext-link>).</p><p id="P22">For affinity pulldown experiments, MBP-fusions of BRCA2 fragments (Ex14, amino-acids 2387-2420, Ex14-Tr, amino acids 2401-2414, Ex27, amino acids 3270-3315, BRC4, amino acids 1519-1551) were cloned into pMAT11 vectors (<xref ref-type="bibr" rid="R36">Peranen et al., 1996</xref>) and co-expressed with DMC1 core, DMC1 core loop mutant (in which DMC1 amino acids 147-GAGGYPG-153 and 178-NVDHDA-183 were replaced by the cognate sequences of RAD51 148-IDRGGGE-154 and 179-GLSGSD-184), RAD51 core, RAD51 core loop mutant (the reverse switch of DMC1 core loop mutant), and RAD51. MBP-fusions and complexes were purified through amylose affinity chromatography.</p></sec><sec id="S10"><title>Crystallisation and structure solution of DMC1 (6R3P)</title><p id="P23">DMC1 ΔN protein crystals were obtained through vapour diffusion in hanging drops, by mixing 1 μl of protein at 15 mg/ml with 1 μl of crystallisation solution (50 mM HEPES-NaOH pH 7.2, 50 mM MgCl<sub>2</sub>, 500 mM NaCl, 7.5 % PEG3350) and equilibrating at 20°C for 2 weeks. Crystals were cryo-protected using 6 M sodium formate and cryo-cooled in liquid nitrogen. X-ray diffraction data were collected at 0.9159 Å, 100 K, as 2000 consecutive 0.10° frames of 0.010 s exposure on a Pilatus 6M detector at beamline I04-1 of the Diamond Light Source synchrotron facility (Oxfordshire, UK). Data were indexed, integrated in XDS (<xref ref-type="bibr" rid="R27">Kabsch, 2010</xref>), scaled in XSCALE (<xref ref-type="bibr" rid="R13">Diederichs et al., 2003</xref>), and merged in Aimless (<xref ref-type="bibr" rid="R19">Evans, 2011</xref>). Crystals belong to orthorhombic spacegroup I422 (cell dimensions a = 174.49 Å, b = 174.49 Å, c = 179.57 Å, α = 90°, β = 90°, γ = 90°), with four DMC1 protomers in the asymmetric unit. Structure solution was achieved through molecular replacement using PHASER (<xref ref-type="bibr" rid="R32">McCoy et al., 2007</xref>), with a single chain from pdb accession 4HYY as a search model. Model building was performed through iterative re-building by PHENIX Autobuild (<xref ref-type="bibr" rid="R2">Adams et al., 2010</xref>) and manual building in Coot (<xref ref-type="bibr" rid="R16">Emsley et al., 2010</xref>), with the addition of PEG ligands. The structure was refined using PHENIX refine (<xref ref-type="bibr" rid="R2">Adams et al., 2010</xref>), using isotropic atomic displacement parameters with two TLS groups per chain. The structure was refined against data to 2.05 Å resolution, to R and Rfree values of 0.1942 and 0.2191 respectively, with 99.07% of residues within favoured regions of the Ramachandran plot (0 outliers), clashscore of 1.28and overall MolProbity score of 0.85 (<xref ref-type="bibr" rid="R8">Chen et al., 2010</xref>).</p></sec><sec id="S11"><title>Crystallisation and structure solution of a BRCA2-DMC1 complex (8R2G)</title><p id="P24">DMC1 ΔN protein crystals were obtained through vapour diffusion in hanging drops, by mixing 1 μl of protein at 20 mg/ml with 1 μl of crystallisation solution (50 mM HEPES-NaOH pH 7.4, 50 mM MgCl<sub>2</sub>, 500 mM NaCl, 8 % PEG 3350) and equilibrating at 20°C for 2 weeks. Crystals were soaked overnight in crystallisation solution containing 3.5 mM BRCA2 Ex14-Tr peptide (RPTKVFVPPFKTKS; synthesised by Severn Biotech). Crystals were cryo-protected using 20 % glycerol and cryo-cooled in liquid nitrogen. X-ray diffraction data were collected at 0.9795 Å, 100 K, as 2000 consecutive 0.10° frames of 0.050 s exposure on a Pilatus3 6M detector at beamline I04 of the Diamond Light Source synchrotron facility (Oxfordshire, UK). Data were processed using AutoPROC (<xref ref-type="bibr" rid="R49">Vonrhein et al., 2011</xref>), in which indexing, integration, scaling and merging were performed by XDS (<xref ref-type="bibr" rid="R27">Kabsch, 2010</xref>) and Aimless (<xref ref-type="bibr" rid="R19">Evans, 2011</xref>), and anisotropic correction with a local I/σ(I) cut-off of 1.2 was performed by STARANISO (<xref ref-type="bibr" rid="R46">Tickle et al., 2018</xref>). Crystals belong to tetragonal spacegroup P4122 (cell dimensions a = 125.40 Å, b = 125.40 Å, c = 364.195 Å, α = 90°, β = 90°, γ = 90°), with one DMC1 octamer in the asymmetric unit. Structure solution was achieved through molecular replacement using Phaser (<xref ref-type="bibr" rid="R32">McCoy et al., 2007</xref>), through placement of four DMC1 dimers from its high-resolution structure (pdb accession 6R3P). The intact molecular replacement solution was refined using PHENIX refine (<xref ref-type="bibr" rid="R2">Adams et al., 2010</xref>) and alternative side-chain conformations were removed. BRCA2 peptides were built using <italic>Alphafold2</italic> models of a BRCA2-DMC1 1:2 complex, which were docked onto the DMC1 protomers of the octameric ring using <italic>PyMOL</italic>.The completed BRCA2-DMC1 structure was refined using PHENIX refine (<xref ref-type="bibr" rid="R2">Adams et al., 2010</xref>), with isotropic atomic displacement parameters, using reference model restraints from the high-resolution DMC1 structure (pdb accession 6R3P). The structure was refined against anisotropy-corrected data with resolution limits between 3.4 Å and 5.8 Å, to R and Rfree values of 0.2635 and 0.3057 respectively, with 98.80% of residues within the favoured regions of the Ramachandran plot (0 outliers), clashscore of 2.88 and overall MolProbity score of 1.08 (<xref ref-type="bibr" rid="R8">Chen et al., 2010</xref>).</p></sec><sec id="S12"><title>Electrophoretic mobility shift assays (EMSAs)</title><p id="P25">To form nucleoprotein filaments, DMC1 and RAD51 was incubated with fluorescent 100-base ssDNA (5’-FAM- AATTCTCATTTTACTTACCGGACGCTATTAGCAGTGGGTGAGCAAAAACAGGAAGGCAAAATGCCGCAAAAAAG GGAATAAGGGCGACACGGAAATGTTG-3’) at the concentrations indicated in the figures for 30 minutes at 4°C in 50 mM TEA (triethanolamine) pH 7.5, 1 mM ATP, 2 mM MgCl<sub>2</sub>, 0.1 mg/ml BSA, 2 mM DTT, 200 mM KCl. For assays requiring incomplete nucleoprotein filament assembly, the reaction buffer consisted of 50 mM TAE (tris, acetate, EDTA) pH 7.5, 2 mM ATP, 2 mM MgCl<sub>2</sub>, 2 mM DTT. In nucleoprotein formation stimulation assays or supershift experiments, BRCA2Ex14 or BRCA2Ex14-AAA were added for a further 30 min at 4°C. For protection experiments, the DMC1, RAD51, or RAD51 L180E-DNA complexes were incubated with BRCA2 Ex14, Ex14-AAA, Ex27, or Ex27-AAA for 30 min at 4°C prior to the addition of BRC4 and further incubation for 30 min at 4°C (concentrations provided in figures). Glycerol was added at a final concentration of 3%, and samples were analysed by electrophoresis on a 1% (w/v) agarose gel in 0.5x TAE pH 8.0 at 20-40 V for ~4 h at 4 °C. DNA was detected by FAM using a TyphoonTM FLA 9500 (GE Healthcare), with 473 nm laser at excitation wavelength 490 nm and emission wavelength 520 nm, using the LPB filter and a PMT voltage of 500 V.</p></sec><sec id="S13"><title>Structural modelling</title><p id="P26">Models were generated using a local installation of <italic>Alphafold2</italic> (<xref ref-type="bibr" rid="R26">Jumper et al., 2021</xref>). Models of BRCA2-DMC1 and BRCA2-RAD51 complexes were generated using a 1:2 ratio of BRCA2 Ex14/Ex27 and DMC1 core and RAD51, respectively. BRCA2-RAD51 models were docked onto a RAD51 filament (<xref ref-type="bibr" rid="R3">Appleby et al., 2023a</xref>; pdb accession: 8BSC), and clashing regions at the N-termini (up to amino-acid 3277) of modelled BRCA2 Ex27 peptides were removed. For comparison between PhePP-binding loops, the BRCA2-DMC1 crystal structure was superposed with the RAD51 core (<xref ref-type="bibr" rid="R35">Pellegrini et al., 2002</xref>; pdb accession 1N0W) using <italic>PyMOL</italic>.</p></sec><sec id="S14"><title>Protein sequence and structure analysis</title><p id="P27">Multiple sequence alignments were generated using <italic>Jalview</italic>(<xref ref-type="bibr" rid="R50">Waterhouse et al., 2009</xref>), and molecular structure images were generated using the <italic>PyMOL</italic> Molecular Graphics System, Version 2.0.4 Schrodinger, LLC.</p></sec></sec><sec sec-type="supplementary-material" id="SM"><title>Supplementary Material</title><supplementary-material content-type="local-data" id="SD1"><label>Supplementary Figures</label><media xlink:href="EMS191470-supplement-Supplementary_Figures.pdf" mimetype="application" mime-subtype="pdf" id="d85aAdEbB" position="anchor"/></supplementary-material></sec></body><back><ack id="S15"><title>Acknowledgements</title><p>We thank Diamond Light Source and the staff of beamlines I04 and I04-1 (proposals mx13587 and mx18598). We thank A. Baslé for assistance with X-ray crystallographic and CD data collection. J.M.D. is a Herchel Smith Fellow. O.R.D. is a Wellcome Senior Research Fellow (Grant Number 219413/Z/19/Z).</p></ack><sec id="S16" sec-type="data-availability"><title>Accession codes and data availability</title><p id="P28">Crystallographic structure factors and atomic co-ordinates have been deposited in the Protein Data Bank (PDB) under accession numbers 6R3P and 8R2G.</p></sec><fn-group><fn id="FN1" fn-type="con"><p id="P29"><bold>Author contributions</bold></p><p id="P30">J.M.D. performed experimental work. O.R.D. solved the crystal structures and wrote the manuscript. J.M.D. and O.R.D. designed experiments and analysed data.</p></fn><fn id="FN2" fn-type="conflict"><p id="P31"><bold>Competing financial interests</bold></p><p id="P32">The authors declare no competing interests.</p></fn></fn-group><ref-list><ref id="R1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Adams</surname><given-names>IR</given-names></name><name><surname>Davies</surname><given-names>OR</given-names></name></person-group><article-title>Meiotic Chromosome Structure, the Synaptonemal Complex, and Infertility</article-title><source>Annu Rev Genomics Hum Genet</source><year>2023</year><pub-id pub-id-type="pmid">37159901</pub-id></element-citation></ref><ref id="R2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Adams</surname><given-names>PD</given-names></name><name><surname>Afonine</surname><given-names>PV</given-names></name><name><surname>Bunkoczi</surname><given-names>G</given-names></name><name><surname>Chen</surname><given-names>VB</given-names></name><name><surname>Davis</surname><given-names>IW</given-names></name><name><surname>Echols</surname><given-names>N</given-names></name><name><surname>Headd</surname><given-names>JJ</given-names></name><name><surname>Hung</surname><given-names>LW</given-names></name><name><surname>Kapral</surname><given-names>GJ</given-names></name><name><surname>Grosse-Kunstleve</surname><given-names>RW</given-names></name><name><surname>Mccoy</surname><given-names>AJ</given-names></name><etal/></person-group><article-title>PHENIX: a comprehensive Python-based system for macromolecular structure solution</article-title><source>Acta Crystallogr D Biol Crystallogr</source><year>2010</year><volume>66</volume><fpage>213</fpage><lpage>21</lpage><pub-id pub-id-type="pmcid">PMC2815670</pub-id><pub-id pub-id-type="pmid">20124702</pub-id><pub-id pub-id-type="doi">10.1107/S0907444909052925</pub-id></element-citation></ref><ref id="R3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Appleby</surname><given-names>R</given-names></name><name><surname>Bollschweiler</surname><given-names>D</given-names></name><name><surname>Chirgadze</surname><given-names>DY</given-names></name><name><surname>Joudeh</surname><given-names>L</given-names></name><name><surname>Pellegrini</surname><given-names>L</given-names></name></person-group><article-title>A metal iondependent mechanism of RAD51 nucleoprotein filament disassembly</article-title><source>iScience</source><year>2023a</year><volume>26</volume><elocation-id>106689</elocation-id><pub-id pub-id-type="pmcid">PMC10192527</pub-id><pub-id pub-id-type="pmid">37216117</pub-id><pub-id pub-id-type="doi">10.1016/j.isci.2023.106689</pub-id></element-citation></ref><ref id="R4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Appleby</surname><given-names>R</given-names></name><name><surname>Joudeh</surname><given-names>L</given-names></name><name><surname>Cobbett</surname><given-names>K</given-names></name><name><surname>Pellegrini</surname><given-names>L</given-names></name></person-group><article-title>Structural basis for stabilisation of the RAD51 nucleoprotein filament by BRCA2</article-title><source>Nat Commun</source><year>2023b</year><volume>14</volume><elocation-id>7003</elocation-id><pub-id pub-id-type="pmcid">PMC10622577</pub-id><pub-id pub-id-type="pmid">37919288</pub-id><pub-id pub-id-type="doi">10.1038/s41467-023-42830-1</pub-id></element-citation></ref><ref id="R5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bell</surname><given-names>JC</given-names></name><name><surname>Dombrowski</surname><given-names>CC</given-names></name><name><surname>Plank</surname><given-names>JL</given-names></name><name><surname>Jensen</surname><given-names>RB</given-names></name><name><surname>Kowalczykowski</surname><given-names>SC</given-names></name></person-group><article-title>BRCA2 chaperones RAD51 to single molecules of RPA-coated ssDNA</article-title><source>Proc Natl Acad Sci U S A</source><year>2023</year><volume>120</volume><elocation-id>e2221971120</elocation-id><pub-id pub-id-type="pmcid">PMC10083600</pub-id><pub-id pub-id-type="pmid">36976771</pub-id><pub-id pub-id-type="doi">10.1073/pnas.2221971120</pub-id></element-citation></ref><ref id="R6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brouwer</surname><given-names>I</given-names></name><name><surname>Moschetti</surname><given-names>T</given-names></name><name><surname>Candelli</surname><given-names>A</given-names></name><name><surname>Garcin</surname><given-names>EB</given-names></name><name><surname>Modesti</surname><given-names>M</given-names></name><name><surname>Pellegrini</surname><given-names>L</given-names></name><name><surname>Wuite</surname><given-names>GJ</given-names></name><name><surname>Peterman</surname><given-names>EJ</given-names></name></person-group><article-title>Two distinct conformational states define the interaction of human RAD51-ATP with single-stranded DNA</article-title><source>EMBO J</source><year>2018</year><fpage>37</fpage><pub-id pub-id-type="pmcid">PMC5881629</pub-id><pub-id pub-id-type="pmid">29507080</pub-id><pub-id pub-id-type="doi">10.15252/embj.201798162</pub-id></element-citation></ref><ref id="R7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carreira</surname><given-names>A</given-names></name><name><surname>Kowalczykowski</surname><given-names>SC</given-names></name></person-group><article-title>Two classes of BRC repeats in BRCA2 promote RAD51 nucleoprotein filament function by distinct mechanisms</article-title><source>Proc Natl Acad Sci U S A</source><year>2011</year><volume>108</volume><elocation-id>1044853</elocation-id><pub-id pub-id-type="pmcid">PMC3127913</pub-id><pub-id pub-id-type="pmid">21670257</pub-id><pub-id pub-id-type="doi">10.1073/pnas.1106971108</pub-id></element-citation></ref><ref id="R8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>VB</given-names></name><name><surname>Arendall</surname><given-names>WB</given-names></name><name><surname>Headd</surname><given-names>JJ</given-names></name><name><surname>Keedy</surname><given-names>DA</given-names></name><name><surname>Immormino</surname><given-names>RM</given-names></name><name><surname>Kapral</surname><given-names>GJ</given-names></name><name><surname>Murray</surname><given-names>LW</given-names></name><name><surname>Richardson</surname><given-names>JS</given-names></name><name><surname>Richardson</surname><given-names>DC</given-names></name></person-group><article-title>MolProbity: all-atom structure validation for macromolecular crystallography</article-title><source>Acta Crystallographica Section D-Biological Crystallography</source><year>2010</year><volume>66</volume><fpage>12</fpage><lpage>21</lpage><pub-id pub-id-type="pmcid">PMC2803126</pub-id><pub-id pub-id-type="pmid">20057044</pub-id><pub-id pub-id-type="doi">10.1107/S0907444909042073</pub-id></element-citation></ref><ref id="R9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Crichton</surname><given-names>JH</given-names></name><name><surname>Dunce</surname><given-names>JM</given-names></name><name><surname>Dunne</surname><given-names>OM</given-names></name><name><surname>Salmon</surname><given-names>LJ</given-names></name><name><surname>Devenney</surname><given-names>PS</given-names></name><name><surname>Lawson</surname><given-names>J</given-names></name><name><surname>Adams</surname><given-names>IR</given-names></name><name><surname>Davies</surname><given-names>OR</given-names></name></person-group><article-title>Structural maturation of SYCP1-mediated meiotic chromosome synapsis by SYCE3</article-title><source>Nat Struct Mol Biol</source><year>2023</year><volume>30</volume><fpage>188</fpage><lpage>199</lpage><pub-id pub-id-type="pmcid">PMC7614228</pub-id><pub-id pub-id-type="pmid">36635604</pub-id><pub-id pub-id-type="doi">10.1038/s41594-022-00909-1</pub-id></element-citation></ref><ref id="R10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dai</surname><given-names>J</given-names></name><name><surname>Voloshin</surname><given-names>O</given-names></name><name><surname>Potapova</surname><given-names>S</given-names></name><name><surname>Camerini-Otero</surname><given-names>RD</given-names></name></person-group><article-title>Meiotic Knockdown and Complementation Reveals Essential Role of RAD51 in Mouse Spermatogenesis</article-title><source>Cell Rep</source><year>2017</year><volume>18</volume><fpage>1383</fpage><lpage>1394</lpage><pub-id pub-id-type="pmcid">PMC5358547</pub-id><pub-id pub-id-type="pmid">28178517</pub-id><pub-id pub-id-type="doi">10.1016/j.celrep.2017.01.024</pub-id></element-citation></ref><ref id="R11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davies</surname><given-names>AA</given-names></name><name><surname>Masson</surname><given-names>JY</given-names></name><name><surname>Mcilwraith</surname><given-names>MJ</given-names></name><name><surname>Stasiak</surname><given-names>AZ</given-names></name><name><surname>Stasiak</surname><given-names>A</given-names></name><name><surname>Venkitaraman</surname><given-names>AR</given-names></name><name><surname>West</surname><given-names>SC</given-names></name></person-group><article-title>Role of BRCA2 in control of the RAD51 recombination and DNA repair protein</article-title><source>Mol Cell</source><year>2001</year><volume>7</volume><fpage>273</fpage><lpage>82</lpage><pub-id pub-id-type="pmid">11239456</pub-id></element-citation></ref><ref id="R12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davies</surname><given-names>OR</given-names></name><name><surname>Pellegrini</surname><given-names>L</given-names></name></person-group><article-title>Interaction with the BRCA2 C terminus protects RAD51-DNA filaments from disassembly by BRC repeats</article-title><source>Nat Struct Mol Biol</source><year>2007</year><volume>14</volume><fpage>475</fpage><lpage>83</lpage><pub-id pub-id-type="pmcid">PMC2096194</pub-id><pub-id pub-id-type="pmid">17515903</pub-id><pub-id pub-id-type="doi">10.1038/nsmb1251</pub-id></element-citation></ref><ref id="R13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Diederichs</surname><given-names>K</given-names></name><name><surname>Mcsweeney</surname><given-names>S</given-names></name><name><surname>Ravelli</surname><given-names>RB</given-names></name></person-group><article-title>Zero-dose extrapolation as part of macromolecular synchrotron data reduction</article-title><source>Acta Crystallogr D Biol Crystallogr</source><year>2003</year><volume>59</volume><fpage>903</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">12777808</pub-id></element-citation></ref><ref id="R14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Du</surname><given-names>L</given-names></name><name><surname>Luo</surname><given-names>Y</given-names></name></person-group><article-title>Structure of a filament of stacked octamers of human DMC1 recombinase</article-title><source>Acta Crystallogr Sect F Struct Biol Cryst Commun</source><year>2013</year><volume>69</volume><fpage>382</fpage><lpage>6</lpage><pub-id pub-id-type="pmcid">PMC3614161</pub-id><pub-id pub-id-type="pmid">23545642</pub-id><pub-id pub-id-type="doi">10.1107/S1744309113005678</pub-id></element-citation></ref><ref id="R15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dunlop</surname><given-names>MH</given-names></name><name><surname>Dray</surname><given-names>E</given-names></name><name><surname>Zhao</surname><given-names>W</given-names></name><name><surname>Tsai</surname><given-names>MS</given-names></name><name><surname>Wiese</surname><given-names>C</given-names></name><name><surname>Schild</surname><given-names>D</given-names></name><name><surname>Sung</surname><given-names>P</given-names></name></person-group><article-title>RAD51-associated protein 1 (RAD51AP1) interacts with the meiotic recombinase DMC1 through a conserved motif</article-title><source>J Biol Chem</source><year>2011</year><volume>286</volume><fpage>37328</fpage><lpage>34</lpage><pub-id pub-id-type="pmcid">PMC3199480</pub-id><pub-id pub-id-type="pmid">21903585</pub-id><pub-id pub-id-type="doi">10.1074/jbc.M111.290015</pub-id></element-citation></ref><ref id="R16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Emsley</surname><given-names>P</given-names></name><name><surname>Lohkamp</surname><given-names>B</given-names></name><name><surname>Scott</surname><given-names>WG</given-names></name><name><surname>Cowtan</surname><given-names>K</given-names></name></person-group><article-title>Features and development of Coot</article-title><source>Acta Crystallogr D Biol Crystallogr</source><year>2010</year><volume>66</volume><fpage>486</fpage><lpage>501</lpage><pub-id pub-id-type="pmcid">PMC2852313</pub-id><pub-id pub-id-type="pmid">20383002</pub-id><pub-id pub-id-type="doi">10.1107/S0907444910007493</pub-id></element-citation></ref><ref id="R17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Esashi</surname><given-names>F</given-names></name><name><surname>Christ</surname><given-names>N</given-names></name><name><surname>Gannon</surname><given-names>J</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Hunt</surname><given-names>T</given-names></name><name><surname>Jasin</surname><given-names>M</given-names></name><name><surname>West</surname><given-names>SC</given-names></name></person-group><article-title>CDK-dependent phosphorylation of BRCA2 as a regulatory mechanism for recombinatìonal repair</article-title><source>Nature</source><year>2005</year><volume>434</volume><fpage>598</fpage><lpage>604</lpage><pub-id pub-id-type="pmid">15800615</pub-id></element-citation></ref><ref id="R18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Esashi</surname><given-names>F</given-names></name><name><surname>Galkin</surname><given-names>VE</given-names></name><name><surname>Yu</surname><given-names>X</given-names></name><name><surname>Egelman</surname><given-names>EH</given-names></name><name><surname>West</surname><given-names>SC</given-names></name></person-group><article-title>Stabilization of RAD51 nucleoprotein filaments by the C-terminal region of BRCA2</article-title><source>Nat Struct Mol Biol</source><year>2007</year><volume>14</volume><fpage>468</fpage><lpage>74</lpage><pub-id pub-id-type="pmid">17515904</pub-id></element-citation></ref><ref id="R19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Evans</surname><given-names>PR</given-names></name></person-group><article-title>An introduction to data reduction: space-group determination, scaling and intensity statistics</article-title><source>Acta Crystallogr D Biol Crystallogr</source><year>2011</year><volume>67</volume><fpage>282</fpage><lpage>92</lpage><pub-id pub-id-type="pmcid">PMC3069743</pub-id><pub-id pub-id-type="pmid">21460446</pub-id><pub-id pub-id-type="doi">10.1107/S090744491003982X</pub-id></element-citation></ref><ref id="R20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Feng</surname><given-names>W</given-names></name><name><surname>Jasin</surname><given-names>M</given-names></name></person-group><article-title>Homologous Recombination and Replication Fork Protection: BRCA2 and More!</article-title><source>Cold Spring Harb Symp Quant Biol</source><year>2017</year><volume>82</volume><fpage>329</fpage><lpage>338</lpage><pub-id pub-id-type="pmcid">PMC6333483</pub-id><pub-id pub-id-type="pmid">29686033</pub-id><pub-id pub-id-type="doi">10.1101/sqb.2017.82.035006</pub-id></element-citation></ref><ref id="R21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gurusaran</surname><given-names>M</given-names></name><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Zhang</surname><given-names>K</given-names></name><name><surname>Shibuya</surname><given-names>H</given-names></name><name><surname>Davies</surname><given-names>OR</given-names></name></person-group><article-title>MEILB2-BRME1 forms a V-shaped DNA clamp upon BRCA2-binding in meiotìc recombination</article-title><source>bioRxiv</source><year>2023</year><elocation-id>2023.07.04.547728</elocation-id></element-citation></ref><ref id="R22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hall</surname><given-names>JM</given-names></name><name><surname>Lee</surname><given-names>MK</given-names></name><name><surname>Newman</surname><given-names>B</given-names></name><name><surname>Morrow</surname><given-names>JE</given-names></name><name><surname>Anderson</surname><given-names>LA</given-names></name><name><surname>Huey</surname><given-names>B</given-names></name><name><surname>King</surname><given-names>MC</given-names></name></person-group><article-title>Linkage of early-onset familial breast cancer to chromosome 17q21</article-title><source>Science</source><year>1990</year><volume>250</volume><fpage>1684</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">2270482</pub-id></element-citation></ref><ref id="R23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hunter</surname><given-names>N</given-names></name></person-group><article-title>Meiotìc Recombination: The Essence of Heredity</article-title><source>Cold Spring Harb Perspect Biol</source><year>2015</year><fpage>7</fpage><pub-id pub-id-type="pmcid">PMC4665078</pub-id><pub-id pub-id-type="pmid">26511629</pub-id><pub-id pub-id-type="doi">10.1101/cshperspect.a016618</pub-id></element-citation></ref><ref id="R24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Islam</surname><given-names>MN</given-names></name><name><surname>Paquet</surname><given-names>N</given-names></name><name><surname>Fox</surname><given-names>D</given-names><suffix>3RD</suffix></name><name><surname>Dray</surname><given-names>E</given-names></name><name><surname>Zheng</surname><given-names>XF</given-names></name><name><surname>Klein</surname><given-names>H</given-names></name><name><surname>Sung</surname><given-names>P</given-names></name><name><surname>Wang</surname><given-names>W</given-names></name></person-group><article-title>A variant of the breast cancer type 2 susceptibility protein (BRC) repeat is essential for the RECQL5 helicase to interact with RAD51 recombinase for genome stabilization</article-title><source>J Biol Chem</source><year>2012</year><volume>287</volume><fpage>23808</fpage><lpage>18</lpage><pub-id pub-id-type="pmcid">PMC3390654</pub-id><pub-id pub-id-type="pmid">22645136</pub-id><pub-id pub-id-type="doi">10.1074/jbc.M112.375014</pub-id></element-citation></ref><ref id="R25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jensen</surname><given-names>RB</given-names></name><name><surname>Carreira</surname><given-names>A</given-names></name><name><surname>Kowalczykowski</surname><given-names>SC</given-names></name></person-group><article-title>Purified human BRCA2 stimulates RAD51-mediated recombination</article-title><source>Nature</source><year>2010</year><volume>467</volume><fpage>678</fpage><lpage>83</lpage><pub-id pub-id-type="pmcid">PMC2952063</pub-id><pub-id pub-id-type="pmid">20729832</pub-id><pub-id pub-id-type="doi">10.1038/nature09399</pub-id></element-citation></ref><ref id="R26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jumper</surname><given-names>J</given-names></name><name><surname>Evans</surname><given-names>R</given-names></name><name><surname>Pritzel</surname><given-names>A</given-names></name><name><surname>Green</surname><given-names>T</given-names></name><name><surname>Figurnov</surname><given-names>M</given-names></name><name><surname>Ronneberger</surname><given-names>O</given-names></name><name><surname>Tunyasuvunakool</surname><given-names>K</given-names></name><name><surname>Bates</surname><given-names>R</given-names></name><name><surname>Zidek</surname><given-names>A</given-names></name><name><surname>Potapenko</surname><given-names>A</given-names></name><name><surname>Bridgland</surname><given-names>A</given-names></name><etal/></person-group><article-title>Highly accurate protein structure prediction with AlphaFold</article-title><source>Nature</source><year>2021</year><volume>596</volume><fpage>583</fpage><lpage>589</lpage><pub-id pub-id-type="pmcid">PMC8371605</pub-id><pub-id pub-id-type="pmid">34265844</pub-id><pub-id pub-id-type="doi">10.1038/s41586-021-03819-2</pub-id></element-citation></ref><ref id="R27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kabsch</surname><given-names>W</given-names></name></person-group><article-title>Xds</article-title><source>Acta Crystallogr D Biol Crystallogr</source><year>2010</year><volume>66</volume><fpage>125</fpage><lpage>32</lpage><pub-id pub-id-type="pmcid">PMC2815665</pub-id><pub-id pub-id-type="pmid">20124692</pub-id><pub-id pub-id-type="doi">10.1107/S0907444909047337</pub-id></element-citation></ref><ref id="R28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kwon</surname><given-names>Y</given-names></name><name><surname>Rosner</surname><given-names>H</given-names></name><name><surname>Zhao</surname><given-names>W</given-names></name><name><surname>Selemenakis</surname><given-names>P</given-names></name><name><surname>He</surname><given-names>Z</given-names></name><name><surname>Kawale</surname><given-names>AS</given-names></name><name><surname>Katz</surname><given-names>JN</given-names></name><name><surname>Rogers</surname><given-names>CM</given-names></name><name><surname>Neal</surname><given-names>FE</given-names></name><name><surname>Badamchi Shabestari</surname><given-names>A</given-names></name><name><surname>Petrosius</surname><given-names>V</given-names></name><etal/></person-group><article-title>DNA binding and RAD51 engagement by the BRCA2 C-terminus orchestrate DNA repair and replication fork preservation</article-title><source>Nat Commun</source><year>2023</year><volume>14</volume><elocation-id>432</elocation-id><pub-id pub-id-type="pmcid">PMC9879961</pub-id><pub-id pub-id-type="pmid">36702902</pub-id><pub-id pub-id-type="doi">10.1038/s41467-023-36211-x</pub-id></element-citation></ref><ref id="R29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>JY</given-names></name><name><surname>Terakawa</surname><given-names>T</given-names></name><name><surname>Qi</surname><given-names>Z</given-names></name><name><surname>Steinfeld</surname><given-names>JB</given-names></name><name><surname>Redding</surname><given-names>S</given-names></name><name><surname>Kwon</surname><given-names>Y</given-names></name><name><surname>Gaines</surname><given-names>WA</given-names></name><name><surname>Zhao</surname><given-names>W</given-names></name><name><surname>Sung</surname><given-names>P</given-names></name><name><surname>Greene</surname><given-names>EC</given-names></name></person-group><article-title>DNA RECOMBINATION. Base triplet stepping by the Rad51/RecA family of recombinases</article-title><source>Science</source><year>2015</year><volume>349</volume><fpage>977</fpage><lpage>81</lpage><pub-id pub-id-type="pmcid">PMC4580133</pub-id><pub-id pub-id-type="pmid">26315438</pub-id><pub-id pub-id-type="doi">10.1126/science.aab2666</pub-id></element-citation></ref><ref id="R30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>J</given-names></name><name><surname>Doty</surname><given-names>T</given-names></name><name><surname>Gibson</surname><given-names>B</given-names></name><name><surname>Heyer</surname><given-names>WD</given-names></name></person-group><article-title>Human BRCA2 protein promotes RAD51 filament formation on RPA-covered single-stranded DNA</article-title><source>Nat Struct Mol Biol</source><year>2010</year><volume>17</volume><fpage>1260</fpage><lpage>2</lpage><pub-id pub-id-type="pmcid">PMC2952495</pub-id><pub-id pub-id-type="pmid">20729859</pub-id><pub-id pub-id-type="doi">10.1038/nsmb.1904</pub-id></element-citation></ref><ref id="R31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martinez</surname><given-names>JS</given-names></name><name><surname>Von Nicolai</surname><given-names>C</given-names></name><name><surname>Kim</surname><given-names>T</given-names></name><name><surname>Ehlen</surname><given-names>A</given-names></name><name><surname>Mazin</surname><given-names>AV</given-names></name><name><surname>Kowalczykowski</surname><given-names>SC</given-names></name><name><surname>Carreira</surname><given-names>A</given-names></name></person-group><article-title>BRCA2 regulates DMC1-mediated recombination through the BRC repeats</article-title><source>Proc Natl Acad Sci U S A</source><year>2016</year><volume>113</volume><fpage>3515</fpage><lpage>20</lpage><pub-id pub-id-type="pmcid">PMC4822569</pub-id><pub-id pub-id-type="pmid">26976601</pub-id><pub-id pub-id-type="doi">10.1073/pnas.1601691113</pub-id></element-citation></ref><ref id="R32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mccoy</surname><given-names>AJ</given-names></name><name><surname>Grosse-Kunstleve</surname><given-names>RW</given-names></name><name><surname>Adams</surname><given-names>PD</given-names></name><name><surname>Winn</surname><given-names>MD</given-names></name><name><surname>Storoni</surname><given-names>LC</given-names></name><name><surname>Read</surname><given-names>RJ</given-names></name></person-group><article-title>Phaser crystallographic software</article-title><source>Journal of Applied Crystallography</source><year>2007</year><volume>40</volume><fpage>658</fpage><lpage>674</lpage><pub-id pub-id-type="pmcid">PMC2483472</pub-id><pub-id pub-id-type="pmid">19461840</pub-id><pub-id pub-id-type="doi">10.1107/S0021889807021206</pub-id></element-citation></ref><ref id="R33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Page</surname><given-names>SL</given-names></name><name><surname>Hawley</surname><given-names>RS</given-names></name></person-group><article-title>Chromosome choreography: the meiotìc ballet</article-title><source>Science</source><year>2003</year><volume>301</volume><fpage>785</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">12907787</pub-id></element-citation></ref><ref id="R34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Patel</surname><given-names>KJ</given-names></name><name><surname>Yu</surname><given-names>VP</given-names></name><name><surname>Lee</surname><given-names>H</given-names></name><name><surname>Corcoran</surname><given-names>A</given-names></name><name><surname>Thistlethwaite</surname><given-names>FC</given-names></name><name><surname>Evans</surname><given-names>MJ</given-names></name><name><surname>Colledge</surname><given-names>WH</given-names></name><name><surname>Friedman</surname><given-names>LS</given-names></name><name><surname>Ponder</surname><given-names>BA</given-names></name><name><surname>Venkitaraman</surname><given-names>AR</given-names></name></person-group><article-title>Involvement of Brca2 in DNA repair</article-title><source>Mol Cell</source><year>1998</year><volume>1</volume><fpage>347</fpage><lpage>57</lpage><pub-id pub-id-type="pmid">9660919</pub-id></element-citation></ref><ref id="R35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pellegrini</surname><given-names>L</given-names></name><name><surname>Yu</surname><given-names>DS</given-names></name><name><surname>Lo</surname><given-names>T</given-names></name><name><surname>Anand</surname><given-names>S</given-names></name><name><surname>Lee</surname><given-names>M</given-names></name><name><surname>Blundell</surname><given-names>TL</given-names></name><name><surname>Venkitaraman</surname><given-names>AR</given-names></name></person-group><article-title>Insights into DNA recombination from the structure of a RAD51-BRCA2 complex</article-title><source>Nature</source><year>2002</year><volume>420</volume><fpage>287</fpage><lpage>93</lpage><pub-id pub-id-type="pmid">12442171</pub-id></element-citation></ref><ref id="R36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peranen</surname><given-names>J</given-names></name><name><surname>Rikkonen</surname><given-names>M</given-names></name><name><surname>Hyvonen</surname><given-names>M</given-names></name><name><surname>Kaariainen</surname><given-names>L</given-names></name></person-group><article-title>T7 vectors with modified T7lac promoter for expression of proteins in Escherichia coli</article-title><source>Anal Biochem</source><year>1996</year><volume>236</volume><fpage>371</fpage><lpage>3</lpage><pub-id pub-id-type="pmid">8660525</pub-id></element-citation></ref><ref id="R37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pittman</surname><given-names>DL</given-names></name><name><surname>Cobb</surname><given-names>J</given-names></name><name><surname>Schimenti</surname><given-names>KJ</given-names></name><name><surname>Wilson</surname><given-names>LA</given-names></name><name><surname>Cooper</surname><given-names>DM</given-names></name><name><surname>Brignull</surname><given-names>E</given-names></name><name><surname>Handel</surname><given-names>MA</given-names></name><name><surname>Schimenti</surname><given-names>JC</given-names></name></person-group><article-title>Meiotìc prophase arrest with failure of chromosome synapsis in mice deficient for Dmc1, a germline-specific RecA homolog</article-title><source>Mol Cell</source><year>1998</year><volume>1</volume><fpage>697</fpage><lpage>705</lpage><pub-id pub-id-type="pmid">9660953</pub-id></element-citation></ref><ref id="R38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shahid</surname><given-names>T</given-names></name><name><surname>Soroka</surname><given-names>J</given-names></name><name><surname>Kong</surname><given-names>E</given-names></name><name><surname>Malivert</surname><given-names>L</given-names></name><name><surname>Mcilwraith</surname><given-names>MJ</given-names></name><name><surname>Pape</surname><given-names>T</given-names></name><name><surname>West</surname><given-names>SC</given-names></name><name><surname>Zhang</surname><given-names>X</given-names></name></person-group><article-title>Structure and mechanism of action of the BRCA2 breast cancer tumor suppressor</article-title><source>Nat Struct Mol Biol</source><year>2014</year><volume>21</volume><fpage>962</fpage><lpage>968</lpage><pub-id pub-id-type="pmcid">PMC4222816</pub-id><pub-id pub-id-type="pmid">25282148</pub-id><pub-id pub-id-type="doi">10.1038/nsmb.2899</pub-id></element-citation></ref><ref id="R39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sharan</surname><given-names>SK</given-names></name><name><surname>Morimatsu</surname><given-names>M</given-names></name><name><surname>Albrecht</surname><given-names>U</given-names></name><name><surname>Lim</surname><given-names>DS</given-names></name><name><surname>Regel</surname><given-names>E</given-names></name><name><surname>Dinh</surname><given-names>C</given-names></name><name><surname>Sands</surname><given-names>A</given-names></name><name><surname>Eichele</surname><given-names>G</given-names></name><name><surname>Hasty</surname><given-names>P</given-names></name><name><surname>Bradley</surname><given-names>A</given-names></name></person-group><article-title>Embryonic lethality and radiation hypersensitivity mediated by Rad51 in mice lacking Brca2</article-title><source>Nature</source><year>1997</year><volume>386</volume><fpage>804</fpage><lpage>10</lpage><pub-id pub-id-type="pmid">9126738</pub-id></element-citation></ref><ref id="R40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sharan</surname><given-names>SK</given-names></name><name><surname>Pyle</surname><given-names>A</given-names></name><name><surname>Coppola</surname><given-names>V</given-names></name><name><surname>Babus</surname><given-names>J</given-names></name><name><surname>Swaminathan</surname><given-names>S</given-names></name><name><surname>Benedict</surname><given-names>J</given-names></name><name><surname>Swing</surname><given-names>D</given-names></name><name><surname>Martin</surname><given-names>BK</given-names></name><name><surname>Tessarollo</surname><given-names>L</given-names></name><name><surname>Evans</surname><given-names>JP</given-names></name><name><surname>Flaws</surname><given-names>JA</given-names></name><etal/></person-group><article-title>BRCA2 deficiency in mice leads to meiotic impairment and infertility</article-title><source>Development</source><year>2004</year><volume>131</volume><fpage>131</fpage><lpage>42</lpage><pub-id pub-id-type="pmid">14660434</pub-id></element-citation></ref><ref id="R41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sonoda</surname><given-names>E</given-names></name><name><surname>Sasaki</surname><given-names>MS</given-names></name><name><surname>Buerstedde</surname><given-names>JM</given-names></name><name><surname>Bezzubova</surname><given-names>O</given-names></name><name><surname>Shinohara</surname><given-names>A</given-names></name><name><surname>Ogawa</surname><given-names>H</given-names></name><name><surname>Takata</surname><given-names>M</given-names></name><name><surname>Yamaguchi-Iwai</surname><given-names>Y</given-names></name><name><surname>Takeda</surname><given-names>S</given-names></name></person-group><article-title>Rad51-deficient vertebrate cells accumulate chromosomal breaks prior to cell death</article-title><source>EMBO J</source><year>1998</year><volume>17</volume><fpage>598</fpage><lpage>608</lpage><pub-id pub-id-type="pmcid">PMC1170409</pub-id><pub-id pub-id-type="pmid">9430650</pub-id><pub-id pub-id-type="doi">10.1093/emboj/17.2.598</pub-id></element-citation></ref><ref id="R42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>Y</given-names></name><name><surname>Mccorvie</surname><given-names>TJ</given-names></name><name><surname>Yates</surname><given-names>LA</given-names></name><name><surname>Zhang</surname><given-names>X</given-names></name></person-group><article-title>Structural basis of homologous recombination</article-title><source>Cell Mol Life Sci</source><year>2020</year><volume>77</volume><fpage>3</fpage><lpage>18</lpage><pub-id pub-id-type="pmcid">PMC6957567</pub-id><pub-id pub-id-type="pmid">31748913</pub-id><pub-id pub-id-type="doi">10.1007/s00018-019-03365-1</pub-id></element-citation></ref><ref id="R43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thorslund</surname><given-names>T</given-names></name><name><surname>Esashi</surname><given-names>F</given-names></name><name><surname>West</surname><given-names>SC</given-names></name></person-group><article-title>Interactions between human BRCA2 protein and the meiosis-specific recombinase DMC1</article-title><source>EMBO J</source><year>2007</year><volume>26</volume><fpage>2915</fpage><lpage>22</lpage><pub-id pub-id-type="pmcid">PMC1894777</pub-id><pub-id pub-id-type="pmid">17541404</pub-id><pub-id pub-id-type="doi">10.1038/sj.emboj.7601739</pub-id></element-citation></ref><ref id="R44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thorslund</surname><given-names>T</given-names></name><name><surname>Mcilwraith</surname><given-names>MJ</given-names></name><name><surname>Compton</surname><given-names>SA</given-names></name><name><surname>Lekomtsev</surname><given-names>S</given-names></name><name><surname>Petronczki</surname><given-names>M</given-names></name><name><surname>Griffith</surname><given-names>JD</given-names></name><name><surname>West</surname><given-names>SC</given-names></name></person-group><article-title>The breast cancer tumor suppressor BRCA2 promotes the specific targeting of RAD51 to single-stranded DNA</article-title><source>Nat Struct Mol Biol</source><year>2010</year><volume>17</volume><fpage>1263</fpage><lpage>5</lpage><pub-id pub-id-type="pmcid">PMC4041013</pub-id><pub-id pub-id-type="pmid">20729858</pub-id><pub-id pub-id-type="doi">10.1038/nsmb.1905</pub-id></element-citation></ref><ref id="R45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thorslund</surname><given-names>T</given-names></name><name><surname>West</surname><given-names>SC</given-names></name></person-group><article-title>BRCA2: a universal recombinase regulator</article-title><source>Oncogene</source><year>2007</year><volume>26</volume><fpage>7720</fpage><lpage>30</lpage><pub-id pub-id-type="pmid">18066084</pub-id></element-citation></ref><ref id="R46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tickle</surname><given-names>IJ</given-names></name><name><surname>Flensburg</surname><given-names>C</given-names></name><name><surname>Keller</surname><given-names>P</given-names></name><name><surname>Paciorek</surname><given-names>W</given-names></name><name><surname>Sharff</surname><given-names>A</given-names></name><name><surname>Vonrhein</surname><given-names>C</given-names></name><name><surname>Bricogne</surname><given-names>G</given-names></name></person-group><article-title>STARANISO</article-title><source>Cambridge, United Kingdom: Global Phasing Ltd</source><year>2018</year><comment><ext-link ext-link-type="uri" xlink:href="https://staraniso.globalphasing.org/cgi-bin/staraniso.cgi">http://staraniso.globalphasing.org/cgi-bin/staraniso.cgi</ext-link></comment></element-citation></ref><ref id="R47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsuzuki</surname><given-names>T</given-names></name><name><surname>Fujii</surname><given-names>Y</given-names></name><name><surname>Sakumi</surname><given-names>K</given-names></name><name><surname>Tominaga</surname><given-names>Y</given-names></name><name><surname>Nakao</surname><given-names>K</given-names></name><name><surname>Sekiguchi</surname><given-names>M</given-names></name><name><surname>Matsushiro</surname><given-names>A</given-names></name><name><surname>Yoshimura</surname><given-names>Y</given-names></name><name><surname>Moritat</surname></name></person-group><article-title>Targeted disruption of the Rad51 gene leads to lethality in embryonic mice</article-title><source>Proc Natl Acad Sci U S A</source><year>1996</year><volume>93</volume><fpage>6236</fpage><lpage>40</lpage><pub-id pub-id-type="pmcid">PMC39005</pub-id><pub-id pub-id-type="pmid">8692798</pub-id><pub-id pub-id-type="doi">10.1073/pnas.93.13.6236</pub-id></element-citation></ref><ref id="R48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tye</surname><given-names>S</given-names></name><name><surname>Ronson</surname><given-names>GE</given-names></name><name><surname>Morris</surname><given-names>JR</given-names></name></person-group><article-title>A fork in the road: Where homologous recombination and stalled replication fork protection part ways</article-title><source>Semin Cell Dev Biol</source><year>2021</year><volume>113</volume><fpage>14</fpage><lpage>26</lpage><pub-id pub-id-type="pmcid">PMC8082280</pub-id><pub-id pub-id-type="pmid">32653304</pub-id><pub-id pub-id-type="doi">10.1016/j.semcdb.2020.07.004</pub-id></element-citation></ref><ref id="R49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vonrhein</surname><given-names>C</given-names></name><name><surname>Flensburg</surname><given-names>C</given-names></name><name><surname>Keller</surname><given-names>P</given-names></name><name><surname>Sharff</surname><given-names>A</given-names></name><name><surname>Smart</surname><given-names>O</given-names></name><name><surname>Paciorek</surname><given-names>W</given-names></name><name><surname>Womack</surname><given-names>T</given-names></name><name><surname>Bricogne</surname><given-names>G</given-names></name></person-group><article-title>Data processing and analysis with the autoPROC toolbox</article-title><source>Acta Crystallogr D Biol Crystallogr</source><year>2011</year><volume>67</volume><fpage>293</fpage><lpage>302</lpage><pub-id pub-id-type="pmcid">PMC3069744</pub-id><pub-id pub-id-type="pmid">21460447</pub-id><pub-id pub-id-type="doi">10.1107/S0907444911007773</pub-id></element-citation></ref><ref id="R50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Waterhouse</surname><given-names>AM</given-names></name><name><surname>Procter</surname><given-names>JB</given-names></name><name><surname>Martin</surname><given-names>DM</given-names></name><name><surname>Clamp</surname><given-names>M</given-names></name><name><surname>Barton</surname><given-names>GJ</given-names></name></person-group><article-title>Jalview Version 2--a multiple sequence alignment editor and analysis workbench</article-title><source>Bioinformatics</source><year>2009</year><volume>25</volume><fpage>1189</fpage><lpage>91</lpage><pub-id pub-id-type="pmcid">PMC2672624</pub-id><pub-id pub-id-type="pmid">19151095</pub-id><pub-id pub-id-type="doi">10.1093/bioinformatics/btp033</pub-id></element-citation></ref><ref id="R51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wong</surname><given-names>AK</given-names></name><name><surname>Pero</surname><given-names>R</given-names></name><name><surname>Ormonde</surname><given-names>PA</given-names></name><name><surname>Tavtigian</surname><given-names>SV</given-names></name><name><surname>Bartel</surname><given-names>PL</given-names></name></person-group><article-title>RAD51 interacts with the evolutionary conserved BRC motifs in the human breast cancer susceptibility gene brca2</article-title><source>J Biol Chem</source><year>1997</year><volume>272</volume><fpage>31941</fpage><lpage>4</lpage><pub-id pub-id-type="pmid">9405383</pub-id></element-citation></ref><ref id="R52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wright</surname><given-names>WD</given-names></name><name><surname>Shah</surname><given-names>SS</given-names></name><name><surname>Heyer</surname><given-names>WD</given-names></name></person-group><article-title>Homologous recombination and the repair of DNA double-strand breaks</article-title><source>J Biol Chem</source><year>2018</year><volume>293</volume><fpage>10524</fpage><lpage>10535</lpage><pub-id pub-id-type="pmcid">PMC6036207</pub-id><pub-id pub-id-type="pmid">29599286</pub-id><pub-id pub-id-type="doi">10.1074/jbc.TM118.000372</pub-id></element-citation></ref><ref id="R53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>H</given-names></name><name><surname>Jeffrey</surname><given-names>PD</given-names></name><name><surname>Miller</surname><given-names>J</given-names></name><name><surname>Kinnucan</surname><given-names>E</given-names></name><name><surname>Sun</surname><given-names>Y</given-names></name><name><surname>Thoma</surname><given-names>NH</given-names></name><name><surname>Zheng</surname><given-names>N</given-names></name><name><surname>Chen</surname><given-names>PL</given-names></name><name><surname>Lee</surname><given-names>WH</given-names></name><name><surname>Pavletich</surname><given-names>NP</given-names></name></person-group><article-title>BRCA2 function in DNA binding and recombination from a BRCA2-DSS1-ssDNA structure</article-title><source>Science</source><year>2002</year><volume>297</volume><fpage>1837</fpage><lpage>48</lpage><pub-id pub-id-type="pmid">12228710</pub-id></element-citation></ref><ref id="R54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yoshida</surname><given-names>K</given-names></name><name><surname>Kondoh</surname><given-names>G</given-names></name><name><surname>Matsuda</surname><given-names>Y</given-names></name><name><surname>Habu</surname><given-names>T</given-names></name><name><surname>Nishimune</surname><given-names>Y</given-names></name><name><surname>Morita</surname><given-names>T</given-names></name></person-group><article-title>The mouse RecA-like gene Dmc1 is required for homologous chromosome synapsis during meiosis</article-title><source>Mol Cell</source><year>1998</year><volume>1</volume><fpage>707</fpage><lpage>18</lpage><pub-id pub-id-type="pmid">9660954</pub-id></element-citation></ref><ref id="R55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname><given-names>VP</given-names></name><name><surname>Koehler</surname><given-names>M</given-names></name><name><surname>Steinlein</surname><given-names>C</given-names></name><name><surname>Schmid</surname><given-names>M</given-names></name><name><surname>Hanakahi</surname><given-names>LA</given-names></name><name><surname>Van Gool</surname><given-names>AJ</given-names></name><name><surname>West</surname><given-names>SC</given-names></name><name><surname>Venkitaraman</surname><given-names>AR</given-names></name></person-group><article-title>Gross chromosomal rearrangements and genetic exchange between nonhomologous chromosomes following BRCA2 inactivation</article-title><source>Genes Dev</source><year>2000</year><volume>14</volume><fpage>1400</fpage><lpage>6</lpage><pub-id pub-id-type="pmcid">PMC316655</pub-id><pub-id pub-id-type="pmid">10837032</pub-id></element-citation></ref><ref id="R56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yuan</surname><given-names>J</given-names></name><name><surname>Chen</surname><given-names>J</given-names></name></person-group><article-title>FIGNL1-containing protein complex is required for efficient homologous recombination repair</article-title><source>Proc Natl Acad Sci U S A</source><year>2013</year><volume>110</volume><fpage>10640</fpage><lpage>5</lpage><pub-id pub-id-type="pmcid">PMC3696823</pub-id><pub-id pub-id-type="pmid">23754376</pub-id><pub-id pub-id-type="doi">10.1073/pnas.1220662110</pub-id></element-citation></ref><ref id="R57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Fujiwara</surname><given-names>Y</given-names></name><name><surname>Yamamoto</surname><given-names>S</given-names></name><name><surname>Shibuya</surname><given-names>H</given-names></name></person-group><article-title>A meiosis-specific BRCA2 binding protein recruits recombinases to DNA double-strand breaks to ensure homologous recombination</article-title><source>Nat Commun</source><year>2019</year><volume>10</volume><elocation-id>722</elocation-id><pub-id pub-id-type="pmcid">PMC6374363</pub-id><pub-id pub-id-type="pmid">30760716</pub-id><pub-id pub-id-type="doi">10.1038/s41467-019-08676-2</pub-id></element-citation></ref><ref id="R58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Gurusaran</surname><given-names>M</given-names></name><name><surname>Fujiwara</surname><given-names>Y</given-names></name><name><surname>Zhang</surname><given-names>K</given-names></name><name><surname>Echbarthi</surname><given-names>M</given-names></name><name><surname>Vorontsov</surname><given-names>E</given-names></name><name><surname>Guo</surname><given-names>R</given-names></name><name><surname>Pendlebury</surname><given-names>DF</given-names></name><name><surname>Alam</surname><given-names>I</given-names></name><name><surname>Livera</surname><given-names>G</given-names></name><name><surname>Emmanuelle</surname><given-names>M</given-names></name><etal/></person-group><article-title>The BRCA2-MEILB2-BRME1 complex governs meiotìc recombination and impairs the mitotic BRCA2-RAD51 function in cancer cells</article-title><source>Nat Commun</source><year>2020</year><volume>11</volume><elocation-id>2055</elocation-id><pub-id pub-id-type="pmcid">PMC7188823</pub-id><pub-id pub-id-type="pmid">32345962</pub-id><pub-id pub-id-type="doi">10.1038/s41467-020-15954-x</pub-id></element-citation></ref><ref id="R59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Nandakumar</surname><given-names>J</given-names></name><name><surname>Shibuya</surname><given-names>H</given-names></name></person-group><article-title>BRCA2 in mammalian meiosis</article-title><source>Trends Cell Biol</source><year>2022</year><volume>32</volume><fpage>281</fpage><lpage>284</lpage><pub-id pub-id-type="pmid">34625364</pub-id></element-citation></ref><ref id="R60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zickler</surname><given-names>D</given-names></name><name><surname>Kleckner</surname><given-names>N</given-names></name></person-group><article-title>Recombination, Pairing, and Synapsis of Homologs during Meiosis</article-title><source>Cold Spring Harb Perspect Biol</source><year>2015</year><fpage>7</fpage><pub-id pub-id-type="pmcid">PMC4448610</pub-id><pub-id pub-id-type="pmid">25986558</pub-id><pub-id pub-id-type="doi">10.1101/cshperspect.a016626</pub-id></element-citation></ref></ref-list></back><floats-group><fig id="F1" position="float"><label>Figure 1</label><caption><title>Crystal structure of a BRCA2-DMC1 complex.</title><p>(<bold>a</bold>) Schematic of the human BRCA2 sequence (top) with multiple sequence alignments of the exon 14 (middle) and exon 27 (bottom) regions, highlighting their PhePP (FxPP) motifs. (<bold>b</bold>) Crystal structure of the complex between BRCA2 Ex14 peptides and a DMC1 ΔN octameric ring. (<bold>c</bold>) Interaction between the PhePP region of the BRCA2-Exon14 peptide (purple) and a DMC1 protomer (yellow), highlighting the FxPP amino-acids F2406, P2408 and P2409. (<bold>d</bold>) Superposition of the BRCA2-DMC1 structure with the RAD51 core, highlighting how the PhePP-binding loop diverges between recombinases, consisting of 177-FNVD-180 in DMC1 and 178-YGLS-181 in RAD51. (<bold>e</bold>) Microscale thermophoresis (MST) of interactions between BRCA2 peptides and DMC1 ΔN. BRCA2 Ex14 and its truncation (for crystallography) bind to DMC1 core with affinities of 30 μM and 36 μM, respectively, whereas interactions are not detectable for the BRCA2-Ex14-AAA mutant (F2406A, P2408A, P2409A), or for the DMC1 ΔN loop mutant (replacing 147-GAGGYPG-153 and 178-NVDHDA-183 with RAD51 amino-acids IDRGGGE and GLSGSD, respectively). BRCA2 Ex27 binds to DMC1 ΔN with an affinity of &gt;96 μM. (<bold>f-h</bold>) Amylose pull-downs of (<bold>f</bold>) DMC1 ΔN, (<bold>g</bold>) DMC1 ΔN wild-type and loop mutant, and (<bold>h</bold>) DMC1 ΔN F85E mutant, following recombinant co-expression with MBP-BRCA2 Ex14 wild-type, truncation (for crystallography) and AAA mutant, Ex27, BRC4 and free MBP (empty).</p></caption><graphic xlink:href="EMS191470-f001"/></fig><fig id="F2" position="float"><label>Figure 2</label><caption><title>BRCA2 Ex14 stabilises DMC1-ssDNA complexes.</title><p>Electrophoretic mobility shift assay (EMSAs) analysing the ability of BRCA2 Ex14 to bind, promote and protect DMC1-ssDNA fllaments. (<bold>a</bold>) EMSAs using TAE pH 7.5 conditions in which (<bold>i</bold>) DMC1-ssDNA binding is not complete (boxed), demonstrating that (<bold>ii</bold>) BRCA2 Ex14 but not (<bold>iii</bold>) BRCA2 Ex14-AAA mutant promotes the formation of DMC1-ssDNA filaments, using the boxed conditions from panel (<bold>i</bold>). (<bold>b</bold>) EMSAs using TEA pH 7.5 + KCl conditions in which (<bold>i</bold>) DMC1-ssDNA binding is largely complete (boxed), demonstrating that (<bold>ii</bold>) BRCA2 Ex14 but not (<bold>iii</bold>) BRCA2 Ex14-AAA mutant induces a supershift, demonstrating binding to DMC1-ssDNA filaments, using the boxed conditions from panel (<bold>i</bold>). (<bold>c</bold>) EMSAs using TEA pH 7.5 + KCl conditions in which (<bold>i</bold>) DMC1-ssDNA binding is disrupted by a stoichiometric excess of BRC4, demonstrating that (<bold>ii</bold>) BRCA2 Ex14 but not (<bold>iii</bold>) BRCA2 Ex14-AAA mutant protects against BRC4-mediated disruption (dashed, boxed). BRCA2 peptide concentrations are shown as molar ratios with respect to DMC1 protomers. Arrowheads, free ssDNA; yellow arrows, DMC1-ssDNA complexes; blue arrows, BRCA2-DMC1-ssDNA complexes.</p></caption><graphic xlink:href="EMS191470-f002"/></fig><fig id="F3" position="float"><label>Figure 3</label><caption><title>BRCA2 Ex27 stabilises RAD51-ssDNA complexes.</title><p>(<bold>a</bold>) Model of the BRCA2 Ex27-RAD51 filament structure generated by docking BRCA2 Ex27-RAD51 1:2 complex models onto a previously reported structure of the RAD51 filament (<xref ref-type="bibr" rid="R3">Appleby et al., 2023a</xref>; pdb accession: 8BSC). (<bold>b</bold>) The modelled BRCA2 Ex27 peptide includes the PhePP motif (boxed), and a long extension that runs along the interface between adjacent RAD51 promoters, shrouding the F86 self-association interaction. (<bold>c</bold>) The PhePP motif is predicted to bind in the same manner as the BRCA2 Ex14-DMC1 interaction, involving FxPP amino-acids F3298, P3300 and P3301. (<bold>d</bold>) Amylose pull-downs of RAD51 ΔN following recombinant co-expression with MBP-BRCA2 Ex14, Ex27 and its AAA mutant (F3298A, P3300A, P3301A), BRC4 and free MBP (empty). (<bold>e</bold>) EMSAs in which (<bold>i</bold>) RAD51-ssDNA binding is disrupted by a equimolar quantities of BRC4, demonstrating that (<bold>ii</bold>) BRCA2 Ex27 but not (<bold>iii</bold>) BRCA2 Ex14-AAA mutant protects against BRC4-mediated disruption (dashed, boxed), and that (<bold>iv</bold>) RAD51 loop mutant L180E undergoes similar disruption, but (<bold>v</bold>) is not protected by BRCA2 Ex27. BRCA2 peptide concentrations are shown as molar ratios with respect to RAD51 protomers. Arrowheads, free ssDNA; yellow arrows, DMC1-ssDNA complexes; red arrows, BRCA2-RAD51-ssDNA complexes.</p></caption><graphic xlink:href="EMS191470-f003"/></fig><table-wrap id="T1" position="float" orientation="portrait"><label>Table 1</label><caption><title>Data collection, phasing and refinement statistics</title></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="top"/><th align="center" valign="top">DMC1</th><th align="center" valign="top">BRCA2-DMC1</th></tr></thead><tbody><tr><td align="left" valign="top"><bold>PDB accession</bold></td><td align="left" valign="top">6R3P</td><td align="left" valign="top">8R2G</td></tr><tr><td align="left" valign="top" colspan="3"><bold>Data collection</bold></td></tr><tr><td align="left" valign="top">Space group</td><td align="left" valign="top">1422</td><td align="left" valign="top">P4122</td></tr><tr><td align="left" valign="top" colspan="3">Cell dimensions</td></tr><tr><td align="left" valign="top">    <italic>a, b, c</italic> (Å)</td><td align="left" valign="top">174.49, 174.49, 179.57</td><td align="left" valign="top">125.40, 125.40, 364.195</td></tr><tr><td align="left" valign="top">    αß,γ(°)</td><td align="left" valign="top">90, 90, 90</td><td align="left" valign="top">90, 90, 90</td></tr><tr><td align="left" valign="top">Resolution (Å)</td><td align="left" valign="top">47.49 – 2.05 (2.09 – 2.05)<xref ref-type="table-fn" rid="TFN1">*</xref></td><td align="left" valign="top">182.098 – 3.452 (3.692 – 3.452)<xref ref-type="table-fn" rid="TFN1">*</xref></td></tr><tr><td align="left" valign="top">Ellipsoidal resolution (Å) (direction)</td><td align="left" valign="top">N/A</td><td align="left" valign="top">3.395 (a<xref ref-type="table-fn" rid="TFN1">*</xref>)<break/>3.395 (b<xref ref-type="table-fn" rid="TFN1">*</xref>)<break/>5.793 (c<xref ref-type="table-fn" rid="TFN1">*</xref>)</td></tr><tr><td align="left" valign="top"><italic>R</italic><sub>meas</sub></td><td align="left" valign="top">0.096 (2.038)</td><td align="left" valign="top">0.247 (1.500)</td></tr><tr><td align="left" valign="top"><italic>R</italic><sub>pim</sub></td><td align="left" valign="top">0.034 (0.720)</td><td align="left" valign="top">0.072 (0.561)</td></tr><tr><td align="left" valign="top"><italic>I</italic> / σ(I)</td><td align="left" valign="top">19.5 (1.6)</td><td align="left" valign="top">8.0 (1.5)</td></tr><tr><td align="left" valign="top"><italic>CC<sub>1/2</sub></italic></td><td align="left" valign="top">1.000 (0.628)</td><td align="left" valign="top">0.998 (0.386)</td></tr><tr><td align="left" valign="top">Completeness (spherical) (%)</td><td align="left" valign="top">100.0 (100.0)</td><td align="left" valign="top">57.7 (16.1)</td></tr><tr><td align="left" valign="top">Completeness (ellipsoidal) (%)</td><td align="left" valign="top">N/A</td><td align="left" valign="top">93.1 (69.2)</td></tr><tr><td align="left" valign="top">Redundancy</td><td align="left" valign="top">15.0 (15.5)</td><td align="left" valign="top">12.2 (7.1)</td></tr><tr><td align="left" valign="top" colspan="3"><bold>Refinement</bold></td></tr><tr><td align="left" valign="top">Resolution (Å)</td><td align="left" valign="top">47.01 – 2.05</td><td align="left" valign="top">118.6 – 3.452</td></tr><tr><td align="left" valign="top">No. reflections</td><td align="left" valign="top">86291</td><td align="left" valign="top">22652</td></tr><tr><td align="left" valign="top"><italic>R</italic><sub>work</sub> / <italic>R</italic><sub>free</sub></td><td align="left" valign="top">0.1942/0.2191</td><td align="left" valign="top">0.2633/0.3065</td></tr><tr><td align="left" valign="top">No. atoms</td><td align="left" valign="top">8118</td><td align="left" valign="top">15352</td></tr><tr><td align="left" valign="top">    Protein</td><td align="left" valign="top">7736</td><td align="left" valign="top">15352</td></tr><tr><td align="left" valign="top">    Ligand/ion</td><td align="left" valign="top">89</td><td align="left" valign="top">0</td></tr><tr><td align="left" valign="top">    Water</td><td align="left" valign="top">293</td><td align="left" valign="top">0</td></tr><tr><td align="left" valign="top"><italic>B</italic>-factors</td><td align="left" valign="top">58.74</td><td align="left" valign="top">94.23</td></tr><tr><td align="left" valign="top">    Protein</td><td align="left" valign="top">58.51</td><td align="left" valign="top">94.23</td></tr><tr><td align="left" valign="top">    Ligand/ion</td><td align="left" valign="top">90.00</td><td align="left" valign="top">N/A</td></tr><tr><td align="left" valign="top" colspan="3">R.m.s. deviations</td></tr><tr><td align="left" valign="top">    Water</td><td align="left" valign="top">55.27</td><td align="left" valign="top">N/A</td></tr><tr><td align="left" valign="top">    Bond lengths (Å)</td><td align="left" valign="top">0.002</td><td align="left" valign="top">0.002</td></tr><tr><td align="left" valign="top">    Bond angles (°)</td><td align="left" valign="top">0.478</td><td align="left" valign="top">0.480</td></tr></tbody></table><table-wrap-foot><fn id="TFN1"><label>*</label><p id="P33">Values in parentheses are for highest-resolution shell.</p></fn></table-wrap-foot></table-wrap></floats-group></article>